Company / Cash & Equivalents
Verastem, Inc. Cash & Equivalents History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$205.0M
FY2025
5-year range
$21.3M / $205.0M
FY2021-FY2025
Trend
+130.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has increased for 4 consecutive years, from $21M in FY2021 to $205M in FY2025.
Based on SEC 10-K filings.
$205M in FY2025 with a 5-year CAGR of +24.8%.
Improved from $78M to $205M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +39.9%
- 5-Year CAGR
- +24.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Verastem, Inc.'s cash & equivalents has grown for 4 consecutive years.
- 5-year CAGR of +24.8%, indicating consistent growth.
- In FY2025, cash & equivalents increased 130.8% year-over-year.
- Lowest cash & equivalents in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.72 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $205.0M | +130.8% |
| FY2024 | $88.8M | +14.0% |
| FY2023 | $77.9M | +4.0% |
| FY2022 | $74.9M | +252.6% |
| FY2021 | $21.3M | -68.6% |
| FY2020 | $67.8M | +55.8% |
| FY2019 | $43.5M | -66.5% |
| FY2018 | $129.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026